S&P 500
(1.26%) 5 127.79 points
Dow Jones
(1.18%) 38 676 points
Nasdaq
(1.99%) 16 156 points
Oil
(-1.22%) $77.99
Gas
(5.65%) $2.15
Gold
(0.02%) $2 310.10
Silver
(-0.16%) $26.79
Platinum
(0.37%) $966.20
USD/EUR
(-0.35%) $0.929
USD/NOK
(-1.07%) $10.87
USD/GBP
(-0.11%) $0.797
USD/RUB
(0.35%) $91.45

实时更新: Nemaura Medical Inc [NMRD]

交易所: NASDAQ 部门: Healthcare 工业: Medical Devices
最后更新时间4 May 2024 @ 01:57

11.70% $ 0.0430

Live Chart Being Loaded With Signals

Commentary (4 May 2024 @ 01:57):

Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients...

Stats
今日成交量 27 400.00
平均成交量 40 470.00
市值 1.24M
EPS $-0.0700 ( 2024-02-23 )
下一个收益日期 ( $-0.110 ) 2024-07-12
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -0.110
ATR14 $0.00200 (4.65%)
Insider Trading
Date Person Action Amount type
2024-01-05 Ghadar-ghadr Arash Buy 100 000 Common Stock
2022-01-05 Ghadar-ghadr Arash Buy 0
2022-01-28 Natha Salim Buy 8 000 Stock Option (right to buy)
2022-01-28 Moore Thomas Peter Buy 8 000 Stock Option (right to buy)
2022-01-31 Mclarney Justin James Buy 22 293 Common Stock
INSIDER POWER
100.00
Last 26 transactions
Buy: 137 623 617 | Sell: 137 373 875

Nemaura Medical Inc 相关性

10 最正相关
BJDX0.936
BXRX0.923
ALVR0.884
AGIL0.879
MIST0.87
CTSO0.87
BNDX0.869
ADN0.864
NEO0.853
EJH0.848
10 最负相关
ARCE-0.949
DSKE-0.924
TIG-0.898
XOMAP-0.893
MRM-0.892
IMRA-0.883
NESR-0.867
SGII-0.866
NSTS-0.849
ORTX-0.847

你知道吗?

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。

相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Nemaura Medical Inc 财务报表

Annual 2023
营收: $77 044.00
毛利润: $-1.48M (-1 916.30 %)
EPS: $-1.010
FY 2023
营收: $77 044.00
毛利润: $-1.48M (-1 916.30 %)
EPS: $-1.010
FY 2022
营收: $503 906
毛利润: $159 606 (31.67 %)
EPS: $-0.590
FY 2021
营收: $0.00
毛利润: $0.00 (0.00 %)
EPS: $-0.280

Financial Reports:

No articles found.

Nemaura Medical Inc

Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts diabetes prevention and reversal programs. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York.

关于 实时信号

此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。

实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。